Additives in intravenous anesthesia modulates pulmonary inflammation in a model of LPS-induced respiratory distress

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 2, 2009, Pages 176-182

  Haitsma, J J ^a,b   Lachmann, B ^c   Papadakos, P J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; INTERLEUKIN 6; KETALIN; KETAMINE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MIDAZOLAM; MIDAZOLAM MALEATE; PROPOFOL; SODIUM CHLORIDE; SULFITE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GAS ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; GAS EXCHANGE; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG VENTILATION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; RESPIRATORY DISTRESS; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ADJUVANTS, ANESTHESIA; ANESTHESIA, INTRAVENOUS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CXCL2; EDETIC ACID; INTERLEUKIN-6; KETAMINE; LIPOPOLYSACCHARIDES; MIDAZOLAM; PROPOFOL; PULMONARY GAS EXCHANGE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SULFITES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58549087587     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01844.x     Document Type: Article

References (29)

1. Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology 2005 103 : 860 76.
2. Marik PE. Propofol: an immunomodulating agent. Pharmacotherapy 2005 25 : 28S 33S.
3. Herr DL, Kelly K, Hall JB, Ulatowski J, Fulda GJ, Cason B, Hickey R, Nejman AM, Zaloga GP, Teres D. Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Med 2000 26 (Suppl. 4) : S452 62.
4. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005 33 : 1 6 discussion 230-2.
5. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995 108 : 1303 14.
6. Meduri GU. Host defense response and outcome in ARDS. Chest 1997 112 : 1154 8.
7. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F II., Park DR, Pugin J, Skerrett SJ, Hudson LD, Martin TR. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001 164 : 1896 903.
8. Bauer TT, Monton C, Torres A, Cabello H, Fillela X, Maldonado A, Nicolas JM, Zavala E. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000 55 : 46 52.
9. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999 282 : 54 61.
10. Ranieri VM, Giunta F, Suter PM, Slutsky AS. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 2000 284 : 43 4.
11. Haitsma JJ, Uhlig S, Goggel R, Verbrugge SJ, Lachmann U, Lachmann B. Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha. Intensive Care Med 2000 26 : 1515 22.
12. van Helden HP, Kuijpers WC, Steenvoorden D, Go C, Bruijnzeel PL, van Eijk M, Haagsman HP. Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome. Exp Lung Res 1997 23 : 297 316.
13. Vreugdenhil HA, Haitsma JJ, Jansen KJ, Zijlstra J, Plotz FB, Van Dijk JE, Lachmann B, Van Vught H, Heijnen CJ. Ventilator-induced heat shock protein 70 and cytokine mRNA expression in a model of lipopolysaccharide-induced lung inflammation. Intensive Care Med 2003 29 : 915 22.
14. Wheeldon EB, Walker ME, Murphy DJ, Turner CR. Intratracheal aerosolization of endotoxin in the rat: a model of the adult respiratory distress syndrome (ARDS). Lab Anim 1992 26 : 29 37.
15. Haitsma JJ, Papadakos PJ, Lachmann B. Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2004 10 : 18 22.
16. Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tutuncu AS, Slutsky AS. Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2006 173 : 882 9.
17. Adhikari N, Burns KE, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2004 : CD004477.
18. Baker MT, Gregerson MS, Martin SM, Buettner GR. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite. Crit Care Med 2003 31 : 787 92.
19. Macdonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaesth 2003 90 : 221 32.
20. Thompson KA, Goodale DB. The recent development of propofol (DIPRIVAN). Intensive Care Med 2000 26 (Suppl. 4) : S400 4.
21. Chu CH, David Liu D, Hsu YH, Lee KC, Chen HI. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulm Pharmacol Ther 2006 20 : 503 12.
22. Gao J, Zeng BX, Zhou LJ, Yuan SY. Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 2004 92 : 277 9.
23. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005 100 : 810 6.
24. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 1996 156 : 1963 72.
25. dos Santos CC, Okutani D, Hu P, Han B, Crimi E, He X, Keshavjee S, Greenwood C, Slutsky AS, Zhang H, Liu M. Differential gene profiling in acute lung injury identifies injury-specific gene expression. Crit Care Med 2008 36 : 855 65.
26. Liu KD, Glidden DV, Eisner MD, Parsons PE, Ware LB, Wheeler A, Korpak A, Thompson BT, Chertow GM, Matthay MA. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med 2007 35 : 2755 61.
27. Takaono M, Yogosawa T, Okawa-Takatsuji M, Aotsuka S. Effects of intravenous anesthetics on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers. Acta Anaesthesiol Scand 2002 46 : 176 9.
28. Kawasaki T, Ogata M, Kawasaki C, Ogata J, Inoue Y, Shigematsu A. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 1999 89 : 665 9.
29. Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC, Wu CH. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide- activated macrophages. Ann NY Acad Sci 2005 1042 : 262 71.